Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 9,064 shares of Regeneron Pharmaceuticals stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $1,015.43, for a total transaction of $9,203,857.52. Following the transaction, the chief executive officer now owns 55,134 shares […]
3Chopt Investment Partners LLC acquired a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the 4th quarter, HoldingsChannel reports. The fund acquired 599 shares of the biopharmaceutical company’s stock, valued at approximately $526,000. Several other institutional investors also recently bought and sold shares of the company. Eudaimonia Advisors LLC boosted its stake […]
Apexium Financial LP Purchases New Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Regeneron Pharmaceuticals (NASDAQ:REGN) PT Raised to $1,030.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Tokio Marine Asset Management Co. Ltd. raised its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 2,420 shares of the biopharmaceutical company’s stock after buying an additional 81 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in Regeneron Pharmaceuticals were […]